Kevin Starr

Third Rock Ventures - Partner
Summary
Kevin Starr is a highly accomplished professional with an extensive background in the field of finance and entrepreneurship.
He obtained a BS/BA degree with a focus on Mathematics and Business from Colby College before further advancing his education with an MSF in Finance from Boston College Carroll School of Management.
Currently, Kevin serves as a Partner at Third Rock Ventures, showcasing his expertise in venture capital and investment management.
With a remarkable career history, he has held key roles in various organizations, including serving as a Board Member and Start-Up CEO at Sage Therapeutics, highlighting his leadership and strategic acumen.
His experience expands to the realm of investment with positions such as an Investor at Prospect Pictures, demonstrating his diverse skill set in finance and business development.
Kevin Starr's contribution to the growth and development of companies is evident through his roles as a Board Member at several start-ups, including Decibel Therapeutics, MyoKardia, Globalblood Therapeutics, PanOptica, Afferent Pharmaceuticals, Zafgen, Agios, Human Genome Sciences, Alnylam Pharmaceuticals, and Vitae Pharmaceuticals.
Additionally, he has showcased his financial acumen through positions such as the COO & CFO at Millennium Pharmaceuticals, the Corporate Controller at Biogen, and his experience in Business/Finance at Digital Equipment Corporation.
Moreover, Kevin has played significant roles in the executive leadership of organizations, as seen in his tenure on the Executive Committee and as a Board member at Cambridge Savings Bank & Appleton Partners, Inc.
Kevin Starr's diverse experience and expertise make him a valuable asset in the fields of finance, venture capital, business development, and executive leadership.